Insulin sensitizers in nonalcoholic steatohepatitis : Hepatology (original) (raw)
Correspondence
Harrison, Stephen A. M.D.1; Schenker, Steven M.D.2; Cusi, Kenneth M.D., FACP, FACE2
1_Brooke Army Medical Center, Fort Sam Houston, TX_
2_The University of Texas Health Science Center at San Antonio, San Antonio, TX_
E-mail:[email protected]
Potential conflict of interest: Dr. Harrison advises, consults for, and serves on the speaker s bureau of Merck. Dr. Harrison serves on the speaker s bureau of Bristol-Myers Squibb. He also advises Amylin.
Copyright © 2011 American Association for the Study of Liver Diseases.